Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Ueckeroth, Frank"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł :
P2.03b-036 Analysis of Potentially Targetable Mutations in 821 Patients with Squamous cell Lung Cancer Undergoing Routine NGS-Based Molecular Diagnostics: Topic: Biomarkers
Autorzy :
Koleczko, Sophia
Pokaż więcej
Źródło :
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S956-S957
Czasopismo naukowe
Tytuł :
P2.03b-028 Improved Overall Survival Following Implementation of NGS in Routine Diagnostics of Advanced Lung Cancer in Germany: Results of the NGM: Topic: Biomarkers
Autorzy :
Kostenko, Anna
Pokaż więcej
Źródło :
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S950-S951
Czasopismo naukowe
Tytuł :
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients.
Autorzy :
Katharina König
Peifer, Martin
Fassunke, Jana
Ihle, Michaela A.
Künstlinger, Helen
Heydt, Carina
Stamm, Katrin
Ueckeroth, Frank
Vollbrecht, Claudia
Bos, Marc
Gardizi, Masyar
Scheffler, Matthias
Nogova, Lucia
Leenders, Frauke
Albus, Kerstin
Meder, Lydia
Becker, Kerstin
Florin, Alexandra
Rommerscheidt-Fuss, Ursula
Altmüller, Janine
Pokaż więcej
Źródło :
Journal of Thoracic Oncology; Jul2015, Vol. 10 Issue 7, p1049-1057, 9p
Czasopismo naukowe
Tytuł :
Clinical and Pathological Characteristics of KEAP1 - and NFE2L2 -Mutated Non-Small Cell Lung Carcinoma (NSCLC).
Autorzy :
Frank R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Scheffler M; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Merkelbach-Bruse S; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Ihle MA; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Kron A; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Rauer M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD) Research Center and Systems Biology of Ageing Cologne, University of Cologne, Cologne, Germany.
Ueckeroth F; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
König K; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Michels S; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Fischer R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Eisert A; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Fassunke J; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Heydt C; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Serke M; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Department for Pulmonology and Thoracic Oncology, Lung Clinic Hemer, Hemer, Germany.
Ko YD; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Johanniter Hospital, Evangelical Clinics of Bonn, Bonn, Germany.
Gerigk U; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Marien-Hospital Bonn, GFO Clinics Bonn, Bonn, Germany.
Geist T; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Center Practice for Lung and Bronchial Diseases, Düsseldorf, Germany.
Kaminsky B; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Clinic for Pulmonology and Allergology, Bethanien Hospital Solingen, Solingen, Germany.
Heukamp LC; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Clement-Ziza M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD) Research Center and Systems Biology of Ageing Cologne, University of Cologne, Cologne, Germany.
Büttner R; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Wolf J; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. .; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Jul 01; Vol. 24 (13), pp. 3087-3096. Date of Electronic Publication: 2018 Apr 03.
Typ publikacji :
Journal Article
MeSH Terms :
Mutation*
Carcinoma, Non-Small-Cell Lung/*genetics
Carcinoma, Non-Small-Cell Lung/*pathology
Kelch-Like ECH-Associated Protein 1/*genetics
Lung Neoplasms/*genetics
Lung Neoplasms/*pathology
NF-E2-Related Factor 2/*genetics
Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/mortality ; Cell Line, Tumor ; Female ; Genetic Association Studies ; Genetic Predisposition to Disease ; High-Throughput Nucleotide Sequencing ; Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Kelch-Like ECH-Associated Protein 1/metabolism ; Lung Neoplasms/drug therapy ; Lung Neoplasms/mortality ; Male ; NF-E2-Related Factor 2/metabolism ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies